Health
Novel prostate cancer resistance mechanism could be a promising target – Drug Target Review
By inhibiting the activity of microRNA-194 (miR-194), scientists prevented prostate cancer cells from developing treatment resistance.
Posted: 6 January 2021 | Hannah Balfour (Drug Target Review) | No comments yet
By inhibiting the activity of microRNA-194 (miR-194), scientists prevented prostate cancer cells from developing treatment resistance in vitro.
Researchers have identified a new mechanism through which prostate cancer cells convert to a more aggressive subtype in response to hormonal therapies. According to the team, further exploration of their findings may enable scientists to develop more targeted ways to remedy treatment…
-
Noosa News17 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
General19 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Business24 hours agoDown 20% this year, here are 3 reasons why I’m still loading up on Amazon stock
-
General23 hours agoStocks, dollar sink as trade war roils markets